| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
|
| Product No. |
CAS No. |
Name |
Category |
| TP1071A |
1092539-44-0 |
SAR131675 |
Inhibitors of VEGFR pathways
|
| TP1071C |
443913-73-3 |
Vandetanib |
Anti-cancer API
|
| TP1072A |
194413-58-6 |
Semaxanib; SU5416 |
Inhibitors of VEGFR pathways
|
| TP1072C |
184475-35-2 |
Gefitinib |
Anti-cancer API
|
| TP1073A |
343787-29-1, 343787-32-6 (4-methylbenzenesulfonate). |
CP 673451 |
Inhibitors of PDGFR pathways
|
| TP1073C |
302962-49-8 |
Dasatinib |
Anti-cancer API
|
| TP1074A |
341031-54-7, 557795-19-4 (free base), 1126641-10-8 ( Maleic acid) |
Sunitinib Malate; Sutent |
Inhibitors of VEGFR pathways
|
| TP1074A |
341031-54-7, 557795-19-4 (free base), 1126641-10-8 ( Maleic acid) |
Sunitinib Malate; Sutent |
Inhibitors of PDGFR pathways
|
| TP1074C |
639089-54-6 |
Tozasertib |
Anti-cancer API
|
| TP1075A |
332012-40-5, 332013-24-8 (4-methylbenzenesulfonate), 332013-28-2 (2HCl) |
Telatinib; BAY 57-9352 |
Inhibitors of VEGFR pathways
|
| TP1075A |
332012-40-5, 332013-24-8 (4-methylbenzenesulfonate), 332013-28-2 (2HCl) |
Telatinib; BAY 57-9352 |
Inhibitors of PDGFR pathways
|
| TP1075C |
231277-92-2 |
Lapatinib |
Anti-cancer API
|
| TP1076A |
475108-18-0, 682745-41-1 (ClH.H2O), 682745-43-3 (HCL) |
Tivozanib; AV-951 |
Inhibitors of VEGFR pathways
|
| TP1076A |
475108-18-0, 682745-41-1 (ClH.H2O), 682745-43-3 (HCL) |
Tivozanib; AV-951 |
Inhibitors of PDGFR pathways
|
| TP1076C |
319460-85-0 |
Axitinib |
Anti-cancer API
|
| TP1077A |
252916-29-3, 251356-54-4 (sodium salt) |
TSU-68; SU6668 |
Inhibitors of PDGFR pathways
|
| TP1077A |
252916-29-3, 251356-54-4 (sodium salt) |
TSU-68; SU6668 |
Inhibitors of VEGFR pathways
|
| TP1077C |
444731-52-6 |
Pazopanib |
Anti-cancer API
|
| TP1078A |
443913-73-3, 338992-53-3 (TFA), 524722-52-9 (HCl). |
Vandetanib; Zactima |
Inhibitors of VEGFR pathways
|
| TP1078C |
194413-58-6 |
Semaxanib |
Anti-cancer API
|
|
|
|
